BeOne Medicines (ONC) Net Income towards Common Stockholders Growth (5y) (2020 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,384,976.65 Bn | 1,384,976.64 Bn | - |
| 2 | Alterity Therapeutics | 777,208.84 Bn | 777,208.81 Bn | - |
| 3 | Legend Biotech | 2,801.00 Bn | 2,800.10 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,226.01 Bn | 2,225.95 Bn | - |
| 5 | Akari Therapeutics | 605.66 Bn | 605.66 Bn | - |
| 6 | Vertex Pharmaceuticals | 110.17 Bn | 102.92 Bn | 2.59 Bn |
| 7 | Regeneron Pharmaceuticals | 66.86 Bn | 58.11 Bn | 3.31 Bn |
| 8 | Evaxion A | 65.12 Bn | 65.10 Bn | - |
| 9 | Alnylam Pharmaceuticals | 39.94 Bn | 36.94 Bn | 959.66 Mn |
| 10 | BeOne Medicines | - | - | 1.35 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 27.87% |
| Dec 31, 2025 | 16.36% |
| Sep 30, 2025 | 17.99% |
| Jun 30, 2025 | 17.84% |
| Mar 31, 2025 | 14.91% |
| Dec 31, 2024 | 17.77% |
| Sep 30, 2024 | 17.85% |
| Jun 30, 2024 | -3.10% |
| Mar 31, 2024 | -6.66% |
| Dec 31, 2023 | -5.51% |
| Sep 30, 2023 | 27.49% |
| Jun 30, 2023 | -19.43% |
| Mar 31, 2023 | -27.21% |
| Dec 31, 2022 | -31.40% |
| Sep 30, 2022 | -46.52% |
| Jun 30, 2022 | -56.35% |
| Mar 31, 2022 | -53.77% |
| Dec 31, 2021 | -73.48% |
| Sep 30, 2021 | -65.31% |
| Jun 30, 2021 | -81.89% |
| Mar 31, 2021 | 38.10% |
| Dec 31, 2020 | -79.00% |
| Sep 30, 2020 | -98.90% |
| Jun 30, 2020 | -127.86% |
| Mar 31, 2020 | -106.10% |